Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies
The summary for the Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies: Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies
Federal Grant Title: | Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies |
Federal Agency Name: | Centers for Disease Control and Prevention |
Grant Categories: | Health |
Type of Opportunity: | Continuation |
Funding Opportunity Number: | CDC-RFA-DD14-140603CONT16 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.080 |
CFDA Descriptions: | Blood Disorder Program: Prevention, Surveillance, and Research |
Current Application Deadline: | Apr 22, 2016 |
Original Application Deadline: | Apr 22, 2016 |
Posted Date: | Feb 11, 2016 |
Creation Date: | Feb 11, 2016 |
Archive Date: | May 22, 2016 |
Total Program Funding: | $0 |
Maximum Federal Grant Award: | $0 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 50 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- This award will be a continuation of funds intended only for grantees previously awarded under CDC-RFA-DD14-1406: Characterizing the Complications Associated with Therapeutic Blood Transfusions for Hemoglobinapathies, CDC-RFA-DD14-140603CONT16.
- Grant Announcement Contact
- Office of Grant Services (OGS)
Technical Information Management Section (TIMS)
E-mail: [email protected]
Phone: 770-488-2700
[email protected]
Centers for Disease Control and Prevention 770-488-2756 - Similar Government Grants
- • Sickle Cell Data Collection Program
- • Evaluation of Health Promotion and Prevention Programs for Blood Disorders
- • Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
- • Capacity Building for Sickle Cell Disease Surveillance
- More Grants from the Centers for Disease Control and Prevention
- • Strengthening Public Health Systems and Services through National Partnerships to Improve ...
- • 93.067
- • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
- • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
- • Strengthening Ebola rapid detection and response capacity through community based surveill...